rs1343637666
Variant summary
Our verdict is Likely benign. The variant received -2 ACMG points: 2P and 4B. PM1BS2
The NM_002047.4(GARS1):c.866G>A(p.Gly289Glu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000479 in 1,461,384 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_002047.4 missense
Scores
Clinical Significance
Conservation
Publications
- Charcot-Marie-Tooth disease type 2DInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), Orphanet
- neuronopathy, distal hereditary motor, type 5AInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), Illumina, Laboratory for Molecular Medicine
- spinal muscular atrophy, infantile, James typeInheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -2 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GARS1 | ENST00000389266.8 | c.866G>A | p.Gly289Glu | missense_variant | Exon 7 of 17 | 1 | NM_002047.4 | ENSP00000373918.3 | ||
GARS1 | ENST00000675651.1 | c.866G>A | p.Gly289Glu | missense_variant | Exon 7 of 17 | ENSP00000502513.1 | ||||
GARS1 | ENST00000675810.1 | c.764G>A | p.Gly255Glu | missense_variant | Exon 6 of 16 | ENSP00000502743.1 | ||||
GARS1 | ENST00000675693.1 | c.698G>A | p.Gly233Glu | missense_variant | Exon 8 of 18 | ENSP00000502174.1 | ||||
GARS1 | ENST00000675051.1 | c.665G>A | p.Gly222Glu | missense_variant | Exon 7 of 17 | ENSP00000502296.1 | ||||
GARS1 | ENST00000674815.1 | c.497G>A | p.Gly166Glu | missense_variant | Exon 7 of 17 | ENSP00000502799.1 | ||||
GARS1 | ENST00000674851.1 | c.497G>A | p.Gly166Glu | missense_variant | Exon 8 of 18 | ENSP00000502451.1 | ||||
GARS1 | ENST00000444666.6 | n.866G>A | non_coding_transcript_exon_variant | Exon 7 of 18 | 3 | ENSP00000415447.2 | ||||
GARS1 | ENST00000674616.1 | n.*580G>A | non_coding_transcript_exon_variant | Exon 8 of 18 | ENSP00000502408.1 | |||||
GARS1 | ENST00000674643.1 | n.866G>A | non_coding_transcript_exon_variant | Exon 7 of 17 | ENSP00000501636.1 | |||||
GARS1 | ENST00000674737.1 | n.*204G>A | non_coding_transcript_exon_variant | Exon 8 of 18 | ENSP00000502464.1 | |||||
GARS1 | ENST00000674807.1 | n.866G>A | non_coding_transcript_exon_variant | Exon 7 of 16 | ENSP00000502814.1 | |||||
GARS1 | ENST00000675529.1 | n.*736G>A | non_coding_transcript_exon_variant | Exon 8 of 18 | ENSP00000501655.1 | |||||
GARS1 | ENST00000675859.1 | n.866G>A | non_coding_transcript_exon_variant | Exon 7 of 15 | ENSP00000502033.1 | |||||
GARS1 | ENST00000676088.1 | n.*808G>A | non_coding_transcript_exon_variant | Exon 9 of 19 | ENSP00000501884.1 | |||||
GARS1 | ENST00000676140.1 | n.866G>A | non_coding_transcript_exon_variant | Exon 7 of 17 | ENSP00000502571.1 | |||||
GARS1 | ENST00000676164.1 | n.*317G>A | non_coding_transcript_exon_variant | Exon 7 of 17 | ENSP00000501986.1 | |||||
GARS1 | ENST00000676210.1 | n.*155G>A | non_coding_transcript_exon_variant | Exon 8 of 18 | ENSP00000502373.1 | |||||
GARS1 | ENST00000676259.1 | n.*298G>A | non_coding_transcript_exon_variant | Exon 7 of 17 | ENSP00000501980.1 | |||||
GARS1 | ENST00000676403.1 | n.866G>A | non_coding_transcript_exon_variant | Exon 7 of 16 | ENSP00000502681.1 | |||||
GARS1 | ENST00000674616.1 | n.*580G>A | 3_prime_UTR_variant | Exon 8 of 18 | ENSP00000502408.1 | |||||
GARS1 | ENST00000674737.1 | n.*204G>A | 3_prime_UTR_variant | Exon 8 of 18 | ENSP00000502464.1 | |||||
GARS1 | ENST00000675529.1 | n.*736G>A | 3_prime_UTR_variant | Exon 8 of 18 | ENSP00000501655.1 | |||||
GARS1 | ENST00000676088.1 | n.*808G>A | 3_prime_UTR_variant | Exon 9 of 19 | ENSP00000501884.1 | |||||
GARS1 | ENST00000676164.1 | n.*317G>A | 3_prime_UTR_variant | Exon 7 of 17 | ENSP00000501986.1 | |||||
GARS1 | ENST00000676210.1 | n.*155G>A | 3_prime_UTR_variant | Exon 8 of 18 | ENSP00000502373.1 | |||||
GARS1 | ENST00000676259.1 | n.*298G>A | 3_prime_UTR_variant | Exon 7 of 17 | ENSP00000501980.1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD2 exomes AF: 0.00000401 AC: 1AN: 249370 AF XY: 0.00 show subpopulations
GnomAD4 exome AF: 0.00000479 AC: 7AN: 1461384Hom.: 0 Cov.: 30 AF XY: 0.00000275 AC XY: 2AN XY: 727006 show subpopulations
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Charcot-Marie-Tooth disease type 2 Uncertain:1
In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. This sequence change replaces glycine, which is neutral and non-polar, with glutamic acid, which is acidic and polar, at codon 289 of the GARS protein (p.Gly289Glu). This variant is present in population databases (no rsID available, gnomAD 0.0008%). This variant has not been reported in the literature in individuals affected with GARS-related conditions. ClinVar contains an entry for this variant (Variation ID: 476763). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt GARS protein function. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at